Summary of Week 2

NOAH FONGWEN: Congratulations. We have now reached the end of week two. And in the course of this week, we saw that according to the 2021 WHO GLASS report, the proportion of patients with infections caused by resistance pathogens for bloodstream infections and common clinical syndromes continue to increase. We also saw that technologies to detect pathogens and determine susceptibility or resistance are easier to use, more affordable, and yielding faster results. We also saw that national AMR programmes can leverage increased molecular testing capacity built for the COVID-19 response, for AMR testing, and surveillance. Next week, we’ll explore how the lessons learned from the COVID-19 pandemic and the technologies developed for the pandemic response can be leveraged to build a more robust AMR programme.

The activities for week three are available to view now. But if you decide to view them early, you may want to return to the comments and discussions while the week is live to see the perspectives of all the learners and to offer your own. At the end of each week, we collate the key thoughts, themes, and any questions from your discussions into a summary document added to the Download section at the bottom of this page.